Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medifast Inc (MED)

Medifast Inc (MED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 111,009
  • Shares Outstanding, K 10,991
  • Annual Sales, $ 385,790 K
  • Annual Income, $ -18,670 K
  • EBIT $ -14 M
  • EBITDA $ -1 M
  • 60-Month Beta 0.52
  • Price/Sales 0.28
  • Price/Cash Flow 24.09
  • Price/Book 0.55

Options Overview Details

View History
  • Implied Volatility 109.39% (+75.61%)
  • Historical Volatility 34.01%
  • IV Percentile 99%
  • IV Rank 91.37%
  • IV High 116.89% on 01/07/26
  • IV Low 30.01% on 03/16/26
  • Expected Move (DTE 23) 0.52 (5.41%)
  • Put/Call Vol Ratio 0.03
  • Today's Volume 94
  • Volume Avg (30-Day) 693
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 28,186
  • Open Int (30-Day) 32,148
  • Expected Range 9.07 to 10.11

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.55
  • Number of Estimates 1
  • High Estimate -0.55
  • Low Estimate -0.55
  • Prior Year -0.11
  • Growth Rate Est. (year over year) -400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.22 +4.01%
on 03/13/26
10.87 -11.78%
on 03/10/26
-0.89 (-8.49%)
since 02/24/26
3-Month
9.22 +4.01%
on 03/13/26
12.14 -21.00%
on 01/26/26
-1.69 (-14.98%)
since 12/24/25
52-Week
9.22 +4.01%
on 03/13/26
15.46 -37.97%
on 07/10/25
-4.56 (-32.23%)
since 03/24/25

Most Recent Stories

More News
Winners And Losers Of Q4: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks

Winners And Losers Of Q4: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks

MED : 9.59 (-5.05%)
Medifast Announces Cooperation Agreement with Steamboat Capital

Company Agrees to Nominate Parsa Kiai and Jeff Rose as Director Candidates at 2026 Annual Meeting of Stockholders

MED : 9.59 (-5.05%)
3 Out-of-Favor Stocks with Open Questions

3 Out-of-Favor Stocks with Open Questions

PZZA : 34.58 (+1.62%)
OLED : 96.00 (+1.99%)
MED : 9.59 (-5.05%)
Medifast’s Q4 Earnings Call: Our Top 5 Analyst Questions

Medifast’s Q4 Earnings Call: Our Top 5 Analyst Questions

MED : 9.59 (-5.05%)
Scientific Evidence Demonstrates OPTAVIA®’s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients

As part of its continued focus on improving metabolic health, Medifast ® (NYSE: MED) today announced that OPTA VIA ’s comprehensive metabolic...

MED : 9.59 (-5.05%)
MED Q4 Deep Dive: Metabolic Health Pivot Drives Early Coach Productivity Gains

MED Q4 Deep Dive: Metabolic Health Pivot Drives Early Coach Productivity Gains

MED : 9.59 (-5.05%)
Medifast: Q4 Earnings Snapshot

Medifast: Q4 Earnings Snapshot

MED : 9.59 (-5.05%)
Medifast’s (NYSE:MED) Q4 CY2025 Sales Top Estimates

Medifast’s (NYSE:MED) Q4 CY2025 Sales Top Estimates

MED : 9.59 (-5.05%)
Medifast Announces Fourth Quarter and Full Year 2025 Financial Results

Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the fourth quarter and full year ended December 31,...

MED : 9.59 (-5.05%)
Earnings To Watch: Medifast (MED) Reports Q4 Results Tomorrow

Earnings To Watch: Medifast (MED) Reports Q4 Results Tomorrow

MED : 9.59 (-5.05%)

Business Summary

Medifast is a leading manufacturer and distributor of clinically-proven healthy living products and programs. The company produces, distributes and sells weight loss, weight management and healthy living products throughits direct online channels as well as franchise weight control centers. The company...

See More

Key Turning Points

3rd Resistance Point 10.58
2nd Resistance Point 10.36
1st Resistance Point 9.98
Last Price 9.59
1st Support Level 9.38
2nd Support Level 9.16
3rd Support Level 8.78

See More

52-Week High 15.46
Fibonacci 61.8% 13.08
Fibonacci 50% 12.34
Fibonacci 38.2% 11.60
Last Price 9.59
52-Week Low 9.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.